Cargando…
Heme iron polypeptide for the treatment of iron deficiency anemia in non-dialysis chronic kidney disease patients: a randomized controlled trial
BACKGROUND: Anemia secondary to iron deficiency is common in patients with non-dialysis dependent chronic kidney disease (ND-CKD) but it is unclear if oral supplementation is as effective as intravenous (IV) supplementation in re-establishing iron stores. The purpose of this study was to determine i...
Autores principales: | Nagaraju, Shankar P, Cohn, Adam, Akbari, Ayub, Davis, Janet L, Zimmerman, Deborah L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606612/ https://www.ncbi.nlm.nih.gov/pubmed/23514036 http://dx.doi.org/10.1186/1471-2369-14-64 |
Ejemplares similares
-
Heme-bound iron in treatment of pregnancy-associated iron deficiency anemia
por: Abdelazim, Ibrahim A., et al.
Publicado: (2018) -
Iron deficiency and iron deficiency anemia in pregnancy
por: Malinowski, A. Kinga, et al.
Publicado: (2021) -
Iron-Refractory Iron Deficiency Anemia
por: Yılmaz Keskin, Ebru, et al.
Publicado: (2015) -
Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial)
por: Barraclough, Katherine A, et al.
Publicado: (2009) -
Iron Deficiency Anemia, Not Iron Deficiency, Is Associated with Reduced Attention in Healthy Young Women
por: Cook, Rebecca L., et al.
Publicado: (2017)